PMCF Investigation of Medical Device ChitoCare® Medical
PMCF Investigation of Medical Device ChitoCare® Medical
This is a post-marketing observational clinical investigation conducted as part of the post-market clinical follow-up of ChitoCare® Medical, aimed to confirm safety and efficacy according to the requirements of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, for the following indications:
Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne
Spray - conditions after dermatosurgical procedures, dermatitis, acne
The inclusion criteria are fully according to indications:
The criteria for exclusion are fully according to contraindications:
craig@chitocare.com+354 846 1912
recepce@euderma.cz+420 246 035 111